Adverum Biotechnologies
ADVM
ADVM
155 hedge funds and large institutions have $1.02B invested in Adverum Biotechnologies in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 51 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 160 → 155 (-5)
17% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 29
34% less call options, than puts
Call options by funds: $7.76M | Put options by funds: $11.8M
Holders
155
Holding in Top 10
5
Calls
$7.76M
Puts
$11.8M
Top Buyers
| 1 | +$20.3M | |
| 2 | +$10.8M | |
| 3 | +$9.94M | |
| 4 |
CC
Casdin Capital
New York
|
+$9.76M |
| 5 |
AG
Artal Group
Luxembourg
|
+$7.59M |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$14.8M | |
| 3 | -$12M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10.3M |
| 5 |
Renaissance Technologies
New York
|
-$4.5M |